PLEGISOL, cardioplegic solution for intracoronary use in a bag bag, 1000 ml
Active ingredients: Calcium chloride, MAGNÉSIUM (CHLORURE DE) HEXAHYDRATÉ, Potassium chloride, Sodium chloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Cardioplegic solutionbag, 1000 mlintracoronaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PLEGISOL, solution cardioplégique pour voie intracoronaire en poche
- Pharmaceutical form
- solution cardioplégique
- Route of administration
- intracoronaire
- Presentation description
- 1 poche(s) PVC de 1000 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62206181CIP75559769CIP133400955597698Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POTASSIUM (CHLORURE DE)solution | 1,193 g · 1000 mL | SA |
| CALCIUM (CHLORURE DE)solution | 0,176 g · 1000 mL | SA |
| SODIUM (CHLORURE DE)solution | 6,43 g · 1000 mL | SA |
| MAGNÉSIUM (CHLORURE DE) HEXAHYDRATÉsolution | 3,253 g · 1000 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.